ESC Premium Access

Obesity paradox outcomes after acute myocardial infarction in Japanese is due to optimal medical therapy in overweight patients

Congress Presentation

About the speaker

Assistant Professor Kenji Sakamoto

Kumamoto University Hospital, Kumamoto (Japan)
0 follower

7 more presentations in this session

Riociguat in transthyretin cardiac amyloidosis-data from a named patient use program in austria

Speaker: Doctor F. Duca (Vienna, AT)


The monocentric, double-blind, placebo-controlled research of sildenafil impact in pediatric patients with secondary pulmonary hypertension.

Speaker: Associate Professor I. Palii (Chisinau, MD)


Elucidating the underlying mechanisms for the differential response to sodium channel blocker antiarrhythmic drugs in obese patients with atrial fibrillation

Speaker: Assistant Professor M. Mccauley (Chicago, US)


The impact of additional mineralocorticoid receptor antagonist on guideline-recommended medical therapy in acute heart failure patients with ischemic heart disease.

Speaker: Doctor T. Abe (Saitama, JP)


Polymorphism RS776746 in the gene of CYP3A5 as a possible predictor of clinical efficiency of bisoprolol in patients transplanted with acute coronary syndrome

Speaker: Doctor V. Shumkov (Saint Petersburg, RU)


Access the full session

Cardiovascular drug therapy in special populations

Speakers: Assistant Professor K. Sakamoto, Doctor F. Duca, Associate Professor I. Palii, Assistant Professor M. Mccauley, Doctor T. Abe...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb